Background The benefit of somatostatin for the prevention of pancreatic fistula has been
debated widely in the literature. The aim of this study was to evaluate the efficacy of …

Background Studies have shown that somatostatin reduces the occurrence of postoperative
pancreatic fistula. However, no study to date has analyzed the cost effectiveness of this …

BACKGROUND: The prophylactic use of somatostatin and its analogs has been suggested
to lower the rate of pancreatic fistula. The aim of this review is to discuss the results of …

Background Prophylactic somatostatin to reduce the incidence of clinically relevant
postoperative pancreatic fistula after pancreaticoduodenectomy remains controversial. We …

Pancreatic surgery is associated with a high morbidity. One of the most frequently seen
major complications is a pancreatic leak or fistula [1]. The incidence of pancreatic leaks …

Background The role of somatostatin and its analogues in reducing complications after
pancreatic resection is controversial. This is a meta-analysis of the evidence of benefit …

Objectives The postoperative morbidity after pancreatectomy remains high. The role of
somatostatin and its analogs in reducing complications after pancreatic resection is …

Background: The use of somatostatin analogues (SAs) following pancreaticoduodenectomy
(PD) is controversial. Method: Literature databases were searched systematically for …

Background Post-operative pancreatic fistula (POPF) is a common complication of
pancreatic resection. Somatostatin analogues (SA) have been used as prophylaxis to …

Background Somatostatin analogues (SA) are currently used to prevent postoperative
pancreatic fistula (POPF) development. However, its use is controversial. This study …